Cite Filings / TRDA / 0001950047-23-000148
Feed Companies Filings Check
Sign in
144

Sale of Securities

Entrada Therapeutics, Inc. · Filed 2023-04-17 · Acc 0001950047-23-000148

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2023-04-27 144 Sale of Securities
  • 2023-04-19 4 President and CEO sold 2,092 shares at $18.01 ($37,675)
  • 2023-04-19 4 Chief Scientific Officer sold 3,961 shares at $18.00 ($71,316)
  • 2023-04-19 4/A President and CEO acquired 49,650 shares (grant or award)
  • 2023-04-19 4/A Chief Scientific Officer acquired 14,200 shares (grant or award)
  • 2023-04-19 4/A Chief Operating Officer acquired 14,200 shares (grant or award)
  • 2023-04-17 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…